Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $128,455,406    

Indirect Value

   $40,265,984      
Total Shares   87,362,343      
Total Value   $168,721,391      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 24 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-07-27 4 B $4.41 $75,871 D/D 17,145 16,477,145 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-15 4 B $0.58 $75,980 I/I 131,000 15,565,500 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-02 4 B $0.53 $77,430 D/D 146,095 3,047,429 2.45 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2018-11-20 4 B $0.38 $77,550 D/D 200,000 19,000,000 2.45 -
VXRT Vaxart Inc 10% Owner   –       –       •   2019-10-03 4 B $0.34 $77,765 D/D 228,720 24,436,000 2.45 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-14 4 B $0.93 $78,974 I/I 85,000 46,100,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-08-30 4 B $3.23 $79,429 D/D 24,591 18,483,233 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-02-24 4 B $0.80 $80,090 I/I 100,000 46,800,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-19 4 B $0.88 $82,053 I/I 93,700 46,400,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-08-16 4 B $2.75 $82,638 I/I 30,000 39,280,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-12-28 4 B $3.12 $82,677 D/D 26,499 18,116,499 3.92 -
VLRX Valeritas Holdings Inc 10% Owner   –       –       •   2018-11-26 4 B $0.38 $83,475 D/D 220,000 19,350,000 2.45 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2018-11-16 4 B $0.47 $83,724 D/D 178,136 17,162,500 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-05-30 4 B $4.64 $84,448 D/D 18,200 18,400,485 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-11-19 4 B $3.51 $84,746 D/D 23,800 17,836,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2018-10-08 4 B $4.33 $84,785 D/D 19,588 17,523,500 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2018-10-22 4 B $4.31 $86,290 D/D 20,000 17,550,000 2.45 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-11-23 4 B $2.32 $86,459 D/D 37,267 30,051,552 3.92 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2020-03-27 4 B $2.43 $87,480 I/I 36,000 752,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-05-29 4 B $4.63 $87,970 D/D 19,000 18,382,285 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2019-03-26 4 B $5.48 $88,984 D/D 16,238 18,294,285 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-16 4 B $0.58 $89,088 I/I 153,600 15,642,300 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2018-10-23 4 B $4.20 $92,365 D/D 22,000 17,572,000 2.45 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2019-03-29 4 B $0.31 $92,439 D/D 298,189 17,812,500 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2018-11-27 4 B $3.51 $93,430 D/D 26,654 17,926,654 2.45 -
  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24  25   26   27   28   29   30   31   32      
  Page 24 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us